Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Scripps Research Institute

Biogen Idec building

Biogen Idec to develop Parkinson’s drugs with Amicus

Companies will develop treatments to target genetic mutation

Biogen Idec building

Biogen Idec gets exclusive access to Isis’ neurology R&D

Fourth deal in two years with antisense specialist

Novartis building

Novartis signs cell therapy deal with Regenerex

Involves platform that could allow transplant patients to live without lifelong immunosuppression

Pharma deals during July 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for July 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Bayer symbol

Bayer to research cancer immunotherapies with Compugen

Will develop drugs that boost response of body’s immune system to tumours

Biogen Idec building

Biogen Idec signs brain research deal with Edinburgh University

Will identify potential treatments for multiple sclerosis and motor neurone disease

- PMLiVE

Ipsen strengthens neurology efforts with Syntaxin purchase

French pharma firm also agrees research deal with Harvard

Deal Watch table for June 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Roche and AstraZeneca to share early trial data

Unique big pharma collaboration aims to increase their R&D efficiency

Bayer symbol

Bayer signs $520m cancer alliance with Seattle Genetics

Will focus on development of antibody-drug conjugates

- PMLiVE

Sanofi and AstraZeneca form cancer research alliances with non-profits

Will work respectively with Curie Institute in France and Cancer Research UK

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links